Cargando…

Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies

Therapeutic monoclonal antibodies (mAbs), including immune checkpoint inhibitors (ICIs), are an important breakthrough for the treatment of cancer and have dramatically changed clinical outcomes in a wide variety of tumours. However, clinical response varies among patients receiving mAb-based treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mata-Molanes, Juan J., Rebollo-Liceaga, Joseba, Martínez-Navarro, Elena Mª, Manzano, Ramón González, Brugarolas, Antonio, Juan, Manel, Sureda, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263556/ https://www.ncbi.nlm.nih.gov/pubmed/35814459 http://dx.doi.org/10.3389/fonc.2022.926289

Ejemplares similares

Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study
por: Escudero-Ortiz, Vanesa, et al.
Publicado: (2022)

A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
por: Mellor, James D, et al.
Publicado: (2013)

Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
por: Liu, Liming
Publicado: (2017)

Monoclonal antibodies and Fc fragments for treating solid tumors
por: Eisenbeis, Andrea M, et al.
Publicado: (2012)

Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
por: Stopforth, Richard J., et al.
Publicado: (2016)

Fc-optimized monoclonal antibodies show superior efficacy
por: Flemming, Alexandra
Publicado: (2021)

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
por: Gogesch, Patricia, et al.
Publicado: (2021)

Monoclonal antibodies in cervical malignancy-related HPV
por: Aghbash, Parisa Shiri, et al.
Publicado: (2022)

Polymorphisms in Fc Gamma Receptors and Susceptibility to Malaria in an Endemic Population
por: Amiah, Mireille Ahou, et al.
Publicado: (2020)

Fc Gamma Receptor IIIB (FcγRIIIB) Polymorphisms Are Associated with Clinical Malaria in Ghanaian Children
por: Adu, Bright, et al.
Publicado: (2012)

Autoimmune mice make anti-Fc gamma receptor antibodies
Publicado: (1990)

Fc-engineered monoclonal antibodies to reduce off-target liver uptake
por: Mangeat, Tristan, et al.
Publicado: (2023)

Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
por: Keeler, Shamus P., et al.
Publicado: (2021)

Novel infusion strategy reduces severe adverse events caused by the anti-GD2 monoclonal antibody naxitamab
por: Varo, Amalia, et al.
Publicado: (2023)

Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models
por: Valente, Delphine, et al.
Publicado: (2020)

Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison
Publicado: (1980)

The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants
por: Delpire, Boris, et al.
Publicado: (2022)

The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
por: Cai, Wen-Qi, et al.
Publicado: (2020)

Acute low back pain as infusion-related reaction to monoclonal antibodies
por: Majenka, Pawel, et al.
Publicado: (2023)

The Relevance of Monoclonal Antibodies in the Treatment of COVID-19
por: Torrente-López, Anabel, et al.
Publicado: (2021)

Specific Antibody and Interferon-Gamma Responses Associated with Immunopathological Forms of Bovine Paratuberculosis in Slaughtered Friesian Cattle
por: Vazquez, Patricia, et al.
Publicado: (2013)

FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies
por: Lang, Isabell, et al.
Publicado: (2022)

Functional study of a monoclonal antibody to IgE Fc receptor (Fc epsilon R2) of eosinophils, platelets, and macrophages
Publicado: (1986)

Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms
por: Pellerin, Alex, et al.
Publicado: (2015)

Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
por: Pierpont, Timothy M., et al.
Publicado: (2018)

Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody‐dependent cellular cytotoxicity
por: Branstetter, Elaine, et al.
Publicado: (2021)

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome
por: Calemma, Rosa, et al.
Publicado: (2012)

Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors
Publicado: (1979)

Purificaton of a functional mouse Fc receptor through the use of a monoclonal antibody
Publicado: (1980)

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review
por: Ramdani, Yanis, et al.
Publicado: (2022)

Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions
por: Zhao, Bo, et al.
Publicado: (2023)

A novel role for the Fc receptor gamma subunit: enhancement of Fc gamma R ligand affinity
Publicado: (1996)

Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
por: Xu, Jiuhui, et al.
Publicado: (2023)

Molecular basis for a polymorphism of human Fc gamma receptor II (CD32)
Publicado: (1990)

Fc gamma receptor polymorphisms in systemic lupus erythematosus and their correlation with the clinical severity of the disease
por: Pradhan, Vandana, et al.
Publicado: (2008)

Fc Gamma Receptor 3A Polymorphism and Risk for HIV-Associated Cryptococcal Disease
por: Rohatgi, Soma, et al.
Publicado: (2013)

Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft Survival
por: Wahrmann, Markus, et al.
Publicado: (2021)

Fc Gamma Receptors in the Hepatic Sinusoid
por: Braathen, Henrik, et al.
Publicado: (2004)

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody
por: Loyau, Jérémy, et al.
Publicado: (2014)

Anti-human CD40 monoclonal antibody therapy is potent without FcR crosslinking
por: Richman, Lee P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6hvetm3jhoscqeumof06ln96mp